KraneShares MSCI All China Health Care Index ETF KURE

Medalist Rating as of | See Kraneshares Investment Hub

Morningstar’s Analysis KURE

Will KURE outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

KraneShares MSCI All China Hlth Care ETF holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings KURE

  • Current Portfolio Date
  • Equity Holdings—
  • Bond Holdings—
  • Other Holdings—
  • % Assets in Top 10 Holdings54.4
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

BeOne Medicines Ltd Ordinary Shares

9.5611M
Healthcare

Innovent Biologics Inc

8.199M
Healthcare

WuXi Biologics (Cayman) Inc

7.609M
Healthcare

Wuxi AppTec Co Ltd Class A

5.546M
Healthcare

Jiangsu Hengrui Pharmaceuticals Co Ltd Class A

4.465M
Healthcare

Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A

4.315M
Healthcare

Akeso Inc Ordinary Shares

4.135M
Healthcare

Sino Biopharmaceutical Ltd

3.884M
Healthcare

CSPC Pharmaceutical Group Ltd

3.484M
Healthcare

Wuxi AppTec Co Ltd

3.224M
Healthcare

Sponsor Center